> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Med-El PMA for Hearing Device
- URL: https://www.fdaweb.com/fda-approves-med-el-pma-for-hearing-device/
- Published: 2016-09-19T12:00:00.000Z
- Updated: 2026-09-14T21:33:18.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5136838

FDA has approved a Med-El USA PMA for the Synchrony EAS (Electric Acoustic Stimulation) Hearing Implant System. The device combines two technologies — a Synchrony cochlear implant that stimulates the auditory nerve for high-frequency hearing loss, and the Sonnet EAS audio processor, with built-in acoustic amplification for low-frequency hearing loss. “The EAS System has the potential to close the gap for people who have high-frequency hearing loss, but whose residual low-frequency hearing would have made them ineligible for a cochlear implant up until now,” the company says.

Approval was based on data that demonstrated 97% of patients participating in the MED-EL EAS clinical trial reported a benefit from the device within the first 12 months. The study also showed that 92% of participants reported an improvement in their ability to hear while there is background noise, and 90% reported satisfaction with the device overall.